Robert M. Plenge
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Systemic Lupus Erythematosus Research, Chronic Lymphocytic Leukemia Research, Rheumatoid Arthritis Research and Therapies, Genetic Associations and Epidemiology, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Genetics of rheumatoid arthritis contributes to biology and drug discovery(2013)2,443 cited
- → Genomic atlas of the human plasma proteome(2018)2,344 cited
- → Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci(2010)1,270 cited
- → STAT4 and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus(2007)1,042 cited
- → Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis(2012)953 cited
- → TRAF1–C5 as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study(2007)829 cited
- → High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis(2012)671 cited
- → A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus(2006)668 cited
- → Replication of Putative Candidate-Gene Associations with Rheumatoid Arthritis in >4,000 Samples from North America and Sweden: Association of Susceptibility with PTPN22, CTLA4, and PADI4(2005)561 cited
- → Two independent alleles at 6q23 associated with risk of rheumatoid arthritis(2007)549 cited